Skip to main content
Lipigon Pharmaceuticals AB (publ) (STO:LPGO)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.0076
+0.0012 (18.75%)
Mar 9, 2026, 5:01 PM CET

STO:LPGO Revenue

Lipigon Pharmaceuticals AB had revenue of 1.32M SEK in the twelve months ending September 30, 2025, down -85.32% year-over-year. In the year 2024, Lipigon Pharmaceuticals AB had annual revenue of 10.29M, down -37.30%.

Revenue (ttm)
1.32M
Revenue Growth
-85.32%
P/S Ratio
3.50
Revenue / Employee
188.14K
Employees
7
Market Cap
4.61M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202410.29M-6.12M-37.30%
Dec 31, 202316.41M--
Dec 31, 2022---
Dec 31, 20212.21M-1.80M-44.86%
Dec 31, 20204.01M2.27M130.20%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Stayble Therapeutics AB 47.00K
NanoEcho AB 487.00K
Fluicell AB 15.22M
Novakand Pharma AB 14.00K
ExpreS2ion Biotech Holding AB 10.85M
Aptahem AB 2.59M
2cureX AB 1.98M
Nanologica AB 21.13M
Revenue Rankings